Empire Asset Management Company initiates coverage on Kythera Biosciences (NASDAQ:KYTH) with a Sell rating.
NEW YORK, Nov. 19, 2013 /PRNewswire/ -- Today Empire Asset Management Company, a FINRA member (143007), initiated coverage of Kythera Biosciences (NASDAQ:KYTH) with a sell rating and 12 month price target of $15.00.
SOURCE Empire Asset Management Company
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
Newsrooms &
Influencers
9k+
Digital Media
Outlets
Digital Media
Outlets
270k+
Journalists
Opted In
Journalists
Opted In
Share this article